Clinical Trials on 不可切除的肝细胞癌 in United States
总计3915个结果
-
University of Texas Southwestern Medical CenterGenentech, Inc.招聘中
-
Mayo ClinicNational Cancer Institute (NCI); United States Department of Defense招聘中
-
Northwestern UniversityBristol-Myers Squibb; National Cancer Institute (NCI)终止
-
Baylor College of MedicineCancer Prevention Research Institute of Texas; The Methodist Hospital Research Institute; Center...完全的
-
H. Lee Moffitt Cancer Center and Research InstituteKaryopharm Therapeutics Inc终止
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Synta Pharmaceuticals Corp.完全的
-
Indiana University School of MedicineCelgene Corporation终止
-
Massachusetts General HospitalEli Lilly and Company; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Genentech... 和其他合作者完全的
-
Massachusetts General HospitalBristol-Myers Squibb; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Brigham...完全的
-
National Cancer Institute (NCI)主动,不招人肝硬化 | 乙型肝炎感染 | 复发性恶性实体瘤 | 转移性恶性实体瘤 | 不可切除的实体瘤 | 复发性肝细胞癌 | 难治性恶性肿瘤 | 丙型肝炎感染 | IV 期肝细胞癌 AJCC v7美国
-
Gilead SciencesArcus Biosciences, Inc.招聘中
-
Scripps Clinic Cancer CenterThreshold Pharmaceuticals未知
-
Wake Forest University Health Sciences招聘中
-
Bristol-Myers Squibb完全的
-
University of Southern CaliforniaNational Cancer Institute (NCI)撤销
-
University of Michigan Rogel Cancer CenterNational Institutes of Health (NIH)完全的
-
Duke UniversityDurham VA Medical Center; Hunter Holmes McGuire VA Medical Center终止
-
Rutgers, The State University of New JerseyRadiological Society of North America未知
-
University of Michigan Rogel Cancer Center撤销
-
Lahey ClinicVarian Medical Systems完全的
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); THERABIONIC INC.暂停
-
M.D. Anderson Cancer CenterGenentech, Inc.; OSI Pharmaceuticals完全的